FDA Inspection 1153969 — Blood Bank Of Delmarva, A Division of New York Blood Center

Blood Bank Of Delmarva, A Division of New York Blood Center — FEI 1000122846

The FDA completed an inspection of Blood Bank Of Delmarva, A Division of New York Blood Center on August 2, 2021 in Salisbury, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 2, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Salisbury, MD (United States)